Stocks and InvestingStocks and Investing
Fri, March 1, 2024
Thu, February 29, 2024

Kristen Kluska Maintained (ADMA) at Buy with Increased Target to $8 on, Feb 29th, 2024


Published on 2024-10-28 09:20:31 - WOPRAI, Kristen Kluska
  Print publication without navigation


Kristen Kluska of Cantor Fitzgerald, Maintained "ADMA Biologics, Inc." (ADMA) at Buy with Increased Target from $6.5 to $8 on, Feb 29th, 2024.

Kristen has made no other calls on ADMA in the last 4 months.



There is 1 other peer that has a rating on ADMA. Out of the 1 peers that are also analyzing ADMA, 0 agree with Kristen's Rating of Hold.



This is the rating of the analyst that currently disagrees with Kristen


  • Anthony Petrone of "Mizuho" Maintained at Strong Buy with Increased Target to $9 on, Monday, January 22nd, 2024